ADBE vs DHR: Which Is the Better Buy?
Side-by-side comparison of Adobe Inc. and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-23.
Adobe Inc. · Technology
$238.25
+13.5% upside to fair value
Med Conviction
Grade B
High Quality
VS
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+29.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ADBE |
DHR |
| Current Price |
$238.25 |
$221.12 |
| Fair Value Estimate |
$270.38 |
$286.52 |
| Upside to Fair Value |
+13.5%
|
+29.6%
|
| Market Cap |
$94.7B |
$155.4B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
9.5x
|
24.8x
|
| Price / Sales |
3.6x
|
6.2x
|
| Price / FCF |
8.6x
|
28.5x
|
| Revenue Growth YoY |
+12.9%
|
+5.5%
|
| Gross Margin |
89.1%
|
58.5%
|
| Operating Margin |
35.7%
|
20.4%
|
| Return on Equity |
62.9%
|
7.7%
|
| Dividend Yield |
0% |
0.65% |
| FCF Yield |
11.63%
|
3.51%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
Adobe is a global software provider organized into Digital Media, Digital Experience, and Publishing and Advertising, with Creative Cloud as its subscription flagship and Document Cloud as its cloud-native document platform. The business quality is high on fundamentals: TTM gross margin of 89.1%, TTM operating margin of 35.7%, TTM net margin of 28.0%, ROE of 62.9%, and free cash flow of $27.69 pe…
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
Accumulation Zones
| Metric |
ADBE |
DHR |
| Zone Low |
$202.78 |
$214.89 |
| Zone High |
$229.82 |
$243.54 |
| In Buy Zone? |
No
|
Yes
|